2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Community-based integrated care versus hospital outpatient care for managing patients with complex type 2 diabetes: costing analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective This study compared the cost of an integrated primary-secondary care general practitioner (GP)-based Beacon model with usual care at hospital outpatient departments (OPDs) for patients with complex type 2 diabetes. Methods A costing analysis was completed alongside a non-inferiority randomised control trial. Costs were calculated using information from accounting data and interviews with clinic managers. Two OPDs and three GP-based Beacon practices participated. In the Beacon practices, GPs with a special interest in advanced diabetes care worked with an endocrinologist and diabetes nurse educator to care for referred patients. The main outcome was incremental cost saving per patient course of treatment from a health system perspective. Uncertainty was characterised with probabilistic sensitivity analysis using Monte Carlo simulation. Results The Beacon model is cost saving: the incremental cost saving per patient was A$365 (95% confidence interval -A$901, A$55) and was cost saving in 93.7% of simulations. The key contributors to the variance in the cost saving per patient course of treatment were the mean number of patients seen per site and the number of additional presentations per course of treatment associated with the Beacon model. Conclusions Beacon clinics were less costly per patient course of treatment than usual care in hospital OPDs for equivalent clinical outcomes. Local contractual arrangements and potential variation in the operational cost structure are of significant consideration in determining the cost-efficiency of Beacon models. What is known about this topic? Despite the growing importance of achieving care quality within constrained budgets, there are few costing studies comparing clinically-equivalent hospital and community-based care models. What does this paper add? Costing analyses comparing hospital-based to GP-based health services require considerable effort and are complex. We show that GP-based Beacon clinics for patients with complex chronic disease can be less costly per patient course of treatment than usual care offered in hospital OPDs. What are the implications for practitioners? In addition to improving access and convenience for patients, transferring care from hospital to the community can reduce health system costs.

          Related collections

          Author and article information

          Journal
          Aust Health Rev
          Australian health review : a publication of the Australian Hospital Association
          CSIRO Publishing
          1449-8944
          0156-5788
          Feb 2021
          : 45
          : 1
          Affiliations
          [1 ] Primary Care Clinical Unit, Faculty of Medicine, The University of Queensland, Herston Road, Herston, Qld 4029, Australia; and Corresponding authors. Email: c.jackson@uq.edu.au; m.donald@uq.edu.au.
          [2 ] Centre for Applied Health Economics, Sir Samuel Griffith Centre, Griffith University, Nathan, Qld 4111, Australia. Email: j.byrnes@griffith.edu.au.
          [3 ] Primary Care Clinical Unit, Faculty of Medicine, The University of Queensland, Herston Road, Herston, Qld 4029, Australia; and Present address: John Walsh Centre for Rehabilitation Research, Sydney Medical School - Northern, The University of Sydney, St Leonards, NSW 2065, Australia. Email: bvai6198@uni.sydney.edu.au.
          [4 ] Faculty of Medicine, The University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102, Australia. Email: anthony.russell2@health.qld.gov.au; and Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102, Australia.
          [5 ] School of Pharmacy, The University of Queensland, 20 Cornwall Street, Woolloongabba, Qld 4102, Australia. Email: s.hollingworth@uq.edu.au.
          Article
          AH19226
          10.1071/AH19226
          33563370
          ade48b1c-34f1-4bef-8d2a-4c11662b23c9
          History

          Comments

          Comment on this article